β¨ Health Notices
18 NOVEMBER 2010 NEW ZEALAND GAZETTE, No. 154 3839
the area of clinical or service competency of each auditor or technical expert approved by the DAA to undertake audits pursuant to the Act.
-
The DAA must provide all documentation to the Ministry in the form prescribed by the Ministry.
-
The DAA must hold third party accreditation with a Ministry-approved third party accreditation body.
This amendment comes into force on the day after this notice is published in the New Zealand Gazette.
Dated this 10th day of November 2010.
STEWART JESSAMINE, Acting Deputy Director-General, Population Health Directorate, Ministry of Health.
go6481
Health Practitioners Competence Assurance Act 2003
Reappointments to the Psychologists Board
Pursuant to section 120 of the Health Practitioners Competence Assurance Act 2003, I reappoint
Dr Frederick Seymour
Dr Lois Surgenor
as members of the Psychologists Board for five-month terms of office commencing on the date of this notification.
Dated at Wellington this 15th day of November 2010.
HON TONY RYALL, Minister of Health.
go8877
Medicines Act 1981
Consent to the Distribution of New Medicines
Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:
Schedule
Product: Clopidogrel Sandoz
Active Ingredient: Clopidogrel bisulfate 97.875mg equivalent to 75mg clopidogrel
Dosage Form: Film coated tablet
New Zealand Sponsor: Novartis New Zealand Limited
Manufacturer: Sandoz Private Limited, Navi Mumbai, India
Product: DP-Acitretin
Active Ingredient: Acitretin 25mg
Dosage Form: Capsule
New Zealand Sponsor: Douglas Pharmaceuticals Limited
Manufacturer: Micro-Sphere S.A, Madonna del Piano, Switzerland
Product: DP-Acitretin
Active Ingredient: Acitretin 10mg
Dosage Form: Capsule
New Zealand Sponsor: Douglas Pharmaceuticals Limited
Manufacturer: Micro-Sphere S.A, Madonna del Piano, Switzerland
Product: DP-Omeprazole
Active Ingredient: Omeprazole 10mg
Dosage Form: Modified release capsule
New Zealand Sponsor: Douglas Pharmaceuticals Limited
Manufacturer: Laboratorios Liconsa S.A., Azuqueca de Henares (Guadalajara), Spain
Product: DP-Omeprazole
Active Ingredient: Omeprazole 20mg
Dosage Form: Modified release capsule
New Zealand Sponsor: Douglas Pharmaceuticals Limited
Manufacturer: Laboratorios Liconsa S.A., Azuqueca de Henares (Guadalajara), Spain
Product: DP-Omeprazole
Active Ingredient: Omeprazole 40mg
Dosage Form: Modified release capsule
New Zealand Sponsor: Douglas Pharmaceuticals Limited
Manufacturer: Laboratorios Liconsa S.A., Azuqueca de Henares (Guadalajara), Spain
Product: Duolin HFA
Active Ingredients: Ipratropium bromide monohydrate 0.021mg equivalent to ipratropium bromide anhydrous 0.020mg
Salbutamol sulfate 0.12mg equivalent to salbutamol 0.100mg
Dosage Form: Aerosol inhaler, metered dose
New Zealand Sponsor: REX Medical Limited
Manufacturer: Cipla Limited, Salcette, India
Next Page →
β¨ LLM interpretation of page content
π₯
Designation of Verification New Zealand Limited as a Designated Auditing Agency
(continued from previous page)
π₯ Health & Social Welfare10 November 2010
Health and Disability Services, Auditing Agency, Hospital Care, Rest Home Care, Residential Disability Care
- STEWART JESSAMINE, Acting Deputy Director-General, Population Health Directorate, Ministry of Health
π₯ Reappointments to the Psychologists Board
π₯ Health & Social Welfare15 November 2010
Psychologists Board, Reappointments
- Frederick Seymour (Dr), Reappointed to Psychologists Board
- Lois Surgenor (Dr), Reappointed to Psychologists Board
- HON TONY RYALL, Minister of Health
π₯ Consent to the Distribution of New Medicines
π₯ Health & Social WelfareMedicines, Distribution, Consent
- Minister of Health
NZ Gazette 2010, No 154